IL153726A0 - Novel aerosol formulation containing a polar fluorinated molecule - Google Patents

Novel aerosol formulation containing a polar fluorinated molecule

Info

Publication number
IL153726A0
IL153726A0 IL15372601A IL15372601A IL153726A0 IL 153726 A0 IL153726 A0 IL 153726A0 IL 15372601 A IL15372601 A IL 15372601A IL 15372601 A IL15372601 A IL 15372601A IL 153726 A0 IL153726 A0 IL 153726A0
Authority
IL
Israel
Prior art keywords
aerosol formulation
formulation containing
polar fluorinated
novel aerosol
fluorinated molecule
Prior art date
Application number
IL15372601A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL153726A0 publication Critical patent/IL153726A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15372601A 2000-07-11 2001-07-10 Novel aerosol formulation containing a polar fluorinated molecule IL153726A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016876.5A GB0016876D0 (en) 2000-07-11 2000-07-11 Novel formulation
PCT/SE2001/001606 WO2002003958A1 (en) 2000-07-11 2001-07-10 Novel aerosol formulation containing a polar fluorinated molecule

Publications (1)

Publication Number Publication Date
IL153726A0 true IL153726A0 (en) 2003-07-06

Family

ID=9895336

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15372601A IL153726A0 (en) 2000-07-11 2001-07-10 Novel aerosol formulation containing a polar fluorinated molecule
IL153726A IL153726A (en) 2000-07-11 2002-12-29 Pharmaceutical preparations containing a drug, a substance that creates a spray and a polar molecule that has undergone fluorination

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153726A IL153726A (en) 2000-07-11 2002-12-29 Pharmaceutical preparations containing a drug, a substance that creates a spray and a polar molecule that has undergone fluorination

Country Status (21)

Country Link
US (1) US20030194378A1 (xx)
EP (1) EP1303258B1 (xx)
JP (1) JP2004502719A (xx)
KR (1) KR20030025265A (xx)
CN (1) CN1455663A (xx)
AT (1) ATE342048T1 (xx)
AU (2) AU2001272866B2 (xx)
BR (1) BR0112322A (xx)
CA (1) CA2415092A1 (xx)
CY (1) CY1105913T1 (xx)
DE (1) DE60123793T2 (xx)
DK (1) DK1303258T3 (xx)
ES (1) ES2273864T3 (xx)
GB (1) GB0016876D0 (xx)
IL (2) IL153726A0 (xx)
MX (1) MXPA03000276A (xx)
NO (1) NO20030133L (xx)
NZ (1) NZ523379A (xx)
PT (1) PT1303258E (xx)
WO (1) WO2002003958A1 (xx)
ZA (1) ZA200300075B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759042A (ja) * 1993-08-13 1995-03-03 Toshiba Corp 画像保管装置
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2002362045A1 (en) * 2001-12-04 2003-06-17 Minnesota High-Tech Resources, Llc Breathable gas mixtures to change body temperature
EP1458357B1 (en) 2001-12-21 2009-03-04 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
BR0307235A (pt) * 2002-02-01 2004-12-07 Atrazeneca Ab Composição para inalação
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
FR2851166A1 (fr) * 2003-02-13 2004-08-20 D Lab Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) * 2005-02-22 2006-08-24 Kai-Volker Schubert Washable leather with repellency
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20090012250A1 (en) * 2007-07-03 2009-01-08 Yu-Chin Lai Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) * 2007-09-13 2009-08-06 재단법인서울대학교산학협력재단 알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
WO2009052519A2 (en) * 2007-10-19 2009-04-23 Wayne State University Co-polymer stabilizers for hydrofluoroalkane dispersions
PT2294044T (pt) * 2008-04-28 2016-09-02 Al Chi Mi A S R L Fluoroalquiloxi-alcanos, processo para a sua produção e suas utilizações
EP2459182B1 (en) * 2009-07-30 2017-09-06 University of Zürich Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
KR101385921B1 (ko) * 2009-10-09 2014-04-15 가부시끼가이샤 구레하 신규의 불화 비닐리덴 공중합체 및 그 제조 방법
EP2407150A1 (de) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants
EP2874737B1 (de) * 2012-07-18 2018-11-07 Merck Patent GmbH Fluortenside
KR101516057B1 (ko) * 2012-12-07 2015-04-30 가톨릭대학교 산학협력단 폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
JP2022527070A (ja) * 2019-04-01 2022-05-30 ハネウェル・インターナショナル・インコーポレーテッド パーソナルケアエアゾール組成物、方法及び装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557294A (en) * 1967-10-12 1971-01-19 Allied Chem Fluorinated ethers as inhalation convulsants
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US5605882A (en) * 1992-05-28 1997-02-25 E. I. Du Pont De Nemours And Company Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
AP835A (en) * 1995-04-14 2000-05-12 Glaxo Wellcome Inc Metered dose inhaler for beclomethasone dipropionate.
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) * 1996-04-16 1998-03-24 E. I. Du Pont De Nemours And Company 1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AU718967B2 (en) * 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
EP1303258B1 (en) 2006-10-11
NZ523379A (en) 2004-06-25
NO20030133D0 (no) 2003-01-10
US20030194378A1 (en) 2003-10-16
WO2002003958A1 (en) 2002-01-17
MXPA03000276A (es) 2003-06-06
BR0112322A (pt) 2003-07-08
DK1303258T3 (da) 2007-01-22
IL153726A (en) 2008-07-08
CA2415092A1 (en) 2002-01-17
EP1303258A1 (en) 2003-04-23
NO20030133L (no) 2003-02-24
GB0016876D0 (en) 2000-08-30
JP2004502719A (ja) 2004-01-29
KR20030025265A (ko) 2003-03-28
CN1455663A (zh) 2003-11-12
ATE342048T1 (de) 2006-11-15
DE60123793T2 (de) 2007-09-06
AU2001272866B2 (en) 2005-08-11
DE60123793D1 (de) 2006-11-23
ES2273864T3 (es) 2007-05-16
CY1105913T1 (el) 2011-04-06
ZA200300075B (en) 2004-04-05
AU7286601A (en) 2002-01-21
PT1303258E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
NZ509328A (en) Medicinal aerosol formulations
ATE342053T1 (de) Formulierungen zur inhalation
PT1014943E (pt) Formulacoes medicinais de aerossois
DE69208660T2 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
MXPA03000442A (es) Una formulacion medicinal en aerosol.
HUP0002691A2 (hu) Ciklezonid tartalmú gyógyászati aeroszol termékek
AP2000001961A0 (en) Pharmaceutical aerosol formulation.
GB2354007B (en) Pharmaceutical formulation of fluticasone propionate
ATE233084T1 (de) Pharmazeutische aerosolformulierung
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
AU1534501A (en) Pharmaceutical formulations of salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
TH29519B (th) สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน